|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 15-05-06 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 15-04-29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| -0.19% | +3.55% | +1.08% | +8.01% | +8.37% | +12.12% | +36.94% | -16.36% | +215.54% | 49.06B | |
| +0.22% | +0.40% | +3.52% | +41.77% | +20.21% | +50.91% | +37.06% | +12.16% | +240.54% | 44.6B | |
| -1.58% | +4.66% | -2.95% | +10.80% | +153.28% | +359.34% | +614.38% | +603.91% | - | 43.24B | |
| +1.70% | +0.36% | +0.07% | +31.12% | +20.80% | +12.56% | +99.27% | +0.88% | +1,114.03% | 41.73B | |
| +0.51% | -1.71% | -6.50% | +7.47% | +3.43% | +5.18% | +46.87% | -17.70% | +133.42% | 29.93B | |
| -0.48% | -1.32% | +2.55% | +16.86% | +9.67% | +23.98% | +150.01% | +228.38% | +1,992.19% | 17.19B | |
| +0.08% | +9.03% | +32.85% | +51.55% | +44.08% | +8.41% | - | - | - | 15.35B | |
| -2.39% | -2.66% | +5.96% | +12.73% | +23.17% | +26.41% | +43.66% | -30.51% | +90.18% | 15.54B | |
| +1.97% | -3.17% | -7.20% | -11.77% | - | - | - | - | - | 15.11B | |
| +0.60% | +5.58% | +1.06% | +36.54% | +47.68% | +98.30% | +50.83% | -29.47% | +252.59% | 14.06B | |
| +1.88% | +3.55% | +3.26% | +3.36% | -3.65% | +7.19% | -28.94% | -33.86% | +127.19% | 13.55B | |
| -1.43% | +2.32% | +22.20% | +239.62% | +233.33% | +156.19% | +100.48% | +41.30% | +1,731.86% | 12.21B | |
| -0.14% | +0.06% | +0.22% | +2.13% | +23.30% | +39.85% | +6.60% | -40.67% | +166.80% | 11.37B | |
| -0.85% | -4.43% | -1.48% | +63.87% | +51.71% | +28.48% | +38.68% | -55.67% | - | 10.86B | |
| +0.04% | -4.82% | -5.21% | +3.59% | +43.94% | +99.11% | +683.22% | +84.15% | - | 9.31B | |
| +0.41% | -1.75% | -1.31% | +16.87% | +63.09% | +111.27% | +731.52% | +681.35% | +580.23% | 9.22B | |
| +1.88% | +0.51% | +4.41% | +14.21% | -4.92% | -2.60% | +1.60% | -21.73% | +42.24% | 9.31B | |
| +2.56% | -0.35% | -11.74% | +3.36% | -28.49% | +21.44% | +474.00% | +194.36% | +1,037.38% | 8.31B | |
| +1.73% | -4.42% | -17.14% | -12.86% | -3.08% | +444.72% | +1,054.14% | -6.70% | - | 7.98B | |
| Average | +0.35% | +0.26% | +1.24% | +28.38% | +39.22% | +83.49% | +243.55% | +93.75% | +594.17% | 18.9B | |
| Weighted average by Cap. | +0.17% | +1.47% | +1.28% | +25.92% | +41.60% | +82.22% | +190.94% | +103.03% | +543.74% |
- Stock Market
- Stocks
- Stock
- Sector Pharmacyclics, Inc.
Select your edition
All financial news and data tailored to specific country editions
